Literature DB >> 11343761

Effect of sex hormones on cardiac mass.

C S Hayward1, C M Webb, P Collins.   

Abstract

Increased left-ventricular mass is an important cardiovascular risk factor for morbidity and mortality. Apart from obvious differences in cardiac size, the changes in left-ventricular mass in response to age and hypertrophic stimuli are very different in men and women. Whereas left-ventricular mass increases with age in apparently healthy women, it remains constant in men. Under increased cardiac loading conditions, such as hypertension or aortic stenosis, this disparity between sexes is even more striking. Findings are especially pronounced in people aged 50 years or older, in whom reproductive hormone concentrations have fallen. Whether the differences in left-ventricular mass changes are related to endogenous sex-hormone concentrations has never been shown. Androgens have anabolic effects on cardiac cells, and oestrogens have antiproliferative properties, we therefore postulate that the normal decline in endogenous sex hormones with age has contrary effects on ventricular mass in men and women in normal and pathological states.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343761     DOI: 10.1016/S0140-6736(00)04523-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  17 in total

1.  Inhibition of angiotensin II induced endothelin-1 gene expression by 17-beta-oestradiol in rat cardiac fibroblasts.

Authors:  H-H Chao; J-J Chen; C-H Chen; H Lin; C-F Cheng; W-S Lian; Y-L Chen; S-H Juan; J-C Liu; J-Y Liou; P Chan; T-H Cheng
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

2.  Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study.

Authors:  Tammy M Brady; Jennifer Roem; Christopher Cox; Michael F Schneider; Amy C Wilson; Susan L Furth; Bradley A Warady; Mark Mitsnefes
Journal:  Am J Kidney Dis       Date:  2020-05-07       Impact factor: 8.860

Review 3.  The influence of sex on left ventricular remodeling in arterial hypertension.

Authors:  Marijana Tadic; Cesare Cuspidi; Guido Grassi
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

Review 4.  Cardiovascular alteration and treatment of hypertension: do men and women differ?

Authors:  Shawna M McBride; Francis W Flynn; Jun Ren
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

Review 5.  Trainability of young athletes and overtraining.

Authors:  Nuno Matos; Richard J Winsley
Journal:  J Sports Sci Med       Date:  2007-09-01       Impact factor: 2.988

6.  Androgen receptor independent cardiovascular action of the antiandrogen flutamide.

Authors:  Radu Iliescu; Luciana A Campos; Wolfgang-Peter Schlegel; Ingo Morano; Ovidiu Baltatu; Michael Bader
Journal:  J Mol Med (Berl)       Date:  2003-06-12       Impact factor: 4.599

7.  Gender-specific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging.

Authors:  Oliver J Rider; Adam Lewandowski; Richard Nethononda; Steffen E Petersen; Jane M Francis; Alex Pitcher; Cameron J Holloway; Sairia Dass; Rajarshi Banerjee; James P Byrne; Paul Leeson; Stefan Neubauer
Journal:  Eur Heart J       Date:  2012-10-10       Impact factor: 29.983

Review 8.  Newer insights into the pathobiological and pharmacological basis of the sex disparity in patients with pulmonary arterial hypertension.

Authors:  Tanvirul Hye; Pankaj Dwivedi; Wei Li; Tim Lahm; Eva Nozik-Grayck; Kurt R Stenmark; Fakhrul Ahsan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-03-10       Impact factor: 6.011

Review 9.  Pulmonary arterial hypertension: basis of sex differences in incidence and treatment response.

Authors:  K M Mair; A K Z Johansen; A F Wright; E Wallace; M R MacLean
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

10.  A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy.

Authors:  Matthias Huber; Susanne Lezius; Rona Reibis; Andras Treszl; Dorota Kujawinska; Stefanie Jakob; Karl Wegscheider; Heinz Völler; Reinhold Kreutz
Journal:  Int J Mol Sci       Date:  2015-07-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.